Domain-substituted IGF2 tag modulates targeting of lentiviral gene therapy for Hunter syndrome.
- DOI
- 10.1038/s44321-025-00314-3
- Published
- 2025 Nov
- Container
- EMBO molecular medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s44321-025-00314-3,
title = {Domain-substituted IGF2 tag modulates targeting of lentiviral gene therapy for Hunter syndrome.},
author = {Catalano F and Stevic D and Zundo G and Huizer TF and Dammou Z and Vlaar EC and Katsavelis D and van den Bosch JC and van den Hout HJMP and Oussoren E and van der Ploeg AT and Ruijter GJG and Schaaf G and Pijnappel WWMP},
year = {2025},
journal = {EMBO molecular medicine},
doi = {10.1038/s44321-025-00314-3},
url = {https://doi.org/10.1038/s44321-025-00314-3}
}RIS
TY - JOUR TI - Domain-substituted IGF2 tag modulates targeting of lentiviral gene therapy for Hunter syndrome. AU - Catalano F AU - Stevic D AU - Zundo G AU - Huizer TF AU - Dammou Z AU - Vlaar EC AU - Katsavelis D AU - van den Bosch JC AU - van den Hout HJMP AU - Oussoren E AU - van der Ploeg AT AU - Ruijter GJG AU - Schaaf G AU - Pijnappel WWMP PY - 2025 JO - EMBO molecular medicine DO - 10.1038/s44321-025-00314-3 UR - https://doi.org/10.1038/s44321-025-00314-3 ER -
APA
F, C., D, S., G, Z., TF, H., Z, D., EC, V., D, K., JC, V. D. B., HJMP, V. D. H., E, O., AT, V. D. P., GJG, R., G, S., & WWMP, P. (2025). Domain-substituted IGF2 tag modulates targeting of lentiviral gene therapy for Hunter syndrome.. EMBO molecular medicine. https://doi.org/10.1038/s44321-025-00314-3
Source records
- pubmed · retrieved 2026-09-26T06:36:14.215Z